CD4 News and Research

RSS

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new study reveals the highest efficacy rates ever reported among patients co-infected with hepatitis C and HIV treated with pegylated interferon and ribavirin.

28 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines and diagnostic tools suited to children, claimed Médecins Sans Frontières at the XV International AIDS Conference in Bangkok.

15 Jul 2004

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

At the XVth International AIDS Conference in Bangkok, Thailand, Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases and chief of the NIAID Laboratory of Immunoregulation (LIR), will present his laboratory’s latest findings on how aberrant immune activation underlies HIV pathogenesis.

15 Jul 2004

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Scientists affiliated with the Harvard University Medical School have devised ways of bolstering patients' immune response against kidney and breast cancer.

15 Jul 2004

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

HIV treatment regimens containing the protease inhibitor (PI) LEXIVA® (fosamprenavir calcium) dosed with ritonavir (LEXIVA/r) or lopinavir (LPV) and ritonavir (LPV/r) were effective in suppressing HIV in patients who had failed prior PI-containing regimens, according to information presented at the International AIDS Conference (IAC).

12 Jul 2004

A new protocol for bone marrow transplants

A new protocol for bone marrow transplants, which does not require the destruction of the recipient’s immune system before transfer of the new bone marrow, is described by a group of Oxford scientists

5 Jul 2004

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

The development of simple and inexpensive generic fixed-dose combined therapies appears the most suitable solution for making possible this access to treatments in developing countries with meagre resources.

3 Jul 2004

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Combination therapy with three generic antiretroviral drugs in a single tablet has been validated for the first time in an open clinical study in a developing country. Follow-up of 60 patients treated in Yaoundé, Cameroon, has demonstrated the excellent efficacy and safety of a generic fixed-dose combination.

2 Jul 2004

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

One of the strategies adopted consists in utilizing combinations of fixed doses of generic antiretrovirals, involving three medicinal drugs of two different classes in the same tablet.

2 Jul 2004

Women delay AIDS with vitamins B, C and E

Daily intake of multivitamins appears to delay the progress of the AIDS virus according to the results of a study of HIV infected women in Tanzania by Harvard researchers.

30 Jun 2004

Discovery may explain why people with AIDS may suffer severe infections from viruses that they would otherwise defeat

Researchers have uncovered the first evidence that a virus can mutate to evade the body's first line of immune defense.

25 Jun 2004

Hair cloning could be the cure for baldness

Researcher Kevin McElwee -- one of only a few people in the world who hold a doctoral degree in hair biology -- thinks a cure for baldness that uses the technique of hair cloning could be commercially available within 10 years.

24 Jun 2004

Mothers infected with HIV who breast feed risk infecting infants

After four weeks of age, infants who breast feed from mothers infected with HIV continue to be at risk for infection with HIV for as long as they breastfeed

17 Jun 2004

Possible new second-generation multiple sclerosis therapy

Scientists from Genencor International, Inc., have demonstrated in an in vivo model that a new variant of recombinant interferon-beta reduces the immunological response to the protein.

25 May 2004

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

24 May 2004

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

In a small study conducted at the U.S. National Institutes of Health (NIH), researchers have shown that it may be feasible to treat HIV-infected patients with a simple, once-daily regimen of anti-HIV drugs given in pre-planned, 7-day-on, 7-day-off cycles. This approach is known formally as “short-cycle structured intermittent antiretroviral therapy” (SIT) or colloquially as the “7-7” approach.

20 May 2004

CD4 News and Research

New drug combination more effective than the previous generation of hepatitis C/HIV therapy

A new vaccine that may delay cancer recurrence

International pharmaceutical industries and governments are failing to develop and produce AIDS medicines

Latest findings on HIV pathogenesis at AIDS Conference in Bangkok

Immunotherapeutic strategy allowing patients to use their own immune system to fight their cancer

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

A new protocol for bone marrow transplants

Inexpensive generic fixed-dose combined therapies appears the most suitable solution for treating AIDS in developing countries

Generic fixed-dose combinations (FDCs) of antiretrovirals are a key factor in access to treatment of HIV/AIDS infection in the developing world

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Women delay AIDS with vitamins B, C and E

Discovery may explain why people with AIDS may suffer severe infections from viruses that they would otherwise defeat

Hair cloning could be the cure for baldness

Mothers infected with HIV who breast feed risk infecting infants

Possible new second-generation multiple sclerosis therapy

Weekly cycles of once-daily anti-HIV drugs could reduce cost of HIV treatment

Weekly cycles of once-daily anti-drugs could reduce cost of HIV treatment

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

Trial of antibody for HIV Infection

Experimental immune-boosting drug interleukin-2 helps HIV Patients

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News